In addition, the recombinant catalytic domain of MT1-MMP could degrade amyloid plaques when incubated ex vivo on brain slices of transgenic AD Tg2576 mice (Liao and Van Nostrand, 2010). The gene discussed is MMP14; the disease is Alzheimer disease.